* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Infection Prevention and Control Team
Survey
Document related concepts
Childhood immunizations in the United States wikipedia , lookup
Rheumatic fever wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Hepatitis C wikipedia , lookup
Urinary tract infection wikipedia , lookup
Sarcocystis wikipedia , lookup
Marburg virus disease wikipedia , lookup
Carbapenem-resistant enterobacteriaceae wikipedia , lookup
Schistosomiasis wikipedia , lookup
Hepatitis B wikipedia , lookup
Coccidioidomycosis wikipedia , lookup
Neonatal infection wikipedia , lookup
Transcript
Infection Prevention and Control Team (IPCT) SECTION 30 GROUP A STREPTOCOCCUS IN A HEATHCARE SETTING WARNING – This document is uncontrolled when printed. Check local intranet site for current version ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 1 of 7 Title of Policy: Group A Streptococcus in a Healthcare Setting Policy Reference: Issue no 1, October 2012 Scope: Organisation Wide Controlled document: This document shall not be copied in part or whole without the express permission of the author or the author's representative. Review Date: October 2015 Author: Frances Lafferty, Senior Infection Control Nurse Policy application / Target Audience Throughout NHS Ayrshire and Arran RESPONISIBILITIES FOR IMPLEMENTATION Organisation: Chief Operating Team Directorate: Directors Corporate: Senior Managers Departmental: Heads of Wards or Departments Local: All relevant staff Policy Statement: It is the responsibility of all staff to ensure that they consistently maintain a high standard of infection control practice in accordance with this guidance to prevent the spread of infections from and between patients with Group A Streptococcus (GAS) Last reviewed: April 2012 Agreed by: Infection Prevention and Control Policy Review Group Electronic approval by: Professor Robert G Masterton Executive Medical Director Date: 5 October 2012 ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 2 of 7 TABLE OF CONTENTS 1.0 INTRODUCTION ...................................................................................4 2.0 NON INVASIVE INFECTION ................................................................4 3.0 INVASIVE INFECTION .........................................................................4 4.0 GENERAL INFORMATION ...................................................................5 5.0 INFECTION CONTROL TRANSMISSION BASED PRECAUTIONS FOR GAS AND IGAS .......................................................................................6 6.0 REFERENCES ......................................................................................7 ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 3 of 7 1.0 INTRODUCTION Group A Streptococcus, (GAS) commonly found in the throat and on the skin, can cause a large variety of infections. Most GAS infections are relatively mild e.g. strep throat or impetigo, however, occasionally these bacteria can cause severe life threatening infections e.g. necrotising fasciitis and toxic shock syndrome (TSS). Outbreaks of infections have been known to occur in surgical, obstetric and burns patients. 2.0 NON INVASIVE INFECTION Most GAS infections are mild and non-invasive, presenting as sore throats, impetigo and cellulitis and are treated with appropriate antibiotics. In obstetrics, post partum fever may be accompanied by local and general signs of GAS infection, however, this can occasionally progress to invasive Group A Streptococcus (iGAS) infection. Scarlet fever (a notifiable disease) which has a characteristic rash may be associated with any of these GAS infections. 3.0 INVASIVE INFECTION Invasive Group A Streptococcal infection (iGAS) occurs when the bacteria get into parts of the body where bacteria are not normally found e.g. blood, lungs, muscle tissue. Necrotising fasciitis destroys muscle, fat and skin tissue TSS causes rapid hypotension and multi organ failure in the early stages of the infection The mortality rate from all forms of iGAS is between 10-20% ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 4 of 7 4.0 GENERAL INFORMATION ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 5 of 7 5.0 INFECTION CONTROL TRANSMISSION BASED PRECAUTIONS FOR GAS AND iGAS Section 2 Transmission Based Precautions (see manual page) covered in this policy document are additional precautions designed to prevent further transmission to be used when an individual is suspected/known to have an infectious agent/disease. Please click here to access all sections of the IPC manual. Patient Placement Patients with suspected/confirmed GAS infection should be isolated in a single room Isolation should continue until they have had at least 24-hours of the appropriate antibiotic therapy and there is a definite clinical improvement If there are no signs of clinical improvement, they should remain isolated until there is a confirmed negative bacterial culture. Care has to be taken with patients who have GAS isolated from wounds, as false negative results can be obtained if the patient is still on antibiotic therapy. In this case they should be isolated until the wound heals, or a negative screen is obtained following completion of antibiotic therapy (also see Section 2 and Section 2 Appendix A of the IPC manual) Hand Hygiene Hands must be decontaminated as per WHO (World Health Organisation) 5 moments for hand hygiene. Detailed guidance can be obtained by clicking the link below Patients should be encouraged to carry out thorough hand hygiene (also see Section 1 Standard Infection Control Precautions in the IPC manual) Personal Protective Equipment (PPE) Plastic aprons and disposable gloves should be worn to prevent direct contact with the patient or the patient’s immediate environment. Hand hygiene must be carried out following removal of PPE. (also see Section 1 Standard Infection Control Precautions in the IPC manual) Linen All linen should be discarded as fouled/infected i.e. placed in a water soluble bag then into a clear plastic bag and lastly into a red laundry bag. Staff should wear appropriate PPE when carrying out this task. (also see Section 1 Standard Infection Control Precautions in the IPC manual) Clinical Waste All waste must be discarded as clinical waste within the isolation room. (also see Section 1 Standard Infection Control Precautions in the IPC manual) Patient Care Equipment Equipment should be kept to a minimum. Prior to removal from the room all equipment must be decontaminated using a chlorine based solution e.g. Actichlor™. Please check manufacturer’s instructions Communal facilities such as baths, bidets and showers should be cleaned and decontaminated between all patients, especially on delivery suites, postnatal wards and other high risk areas such as burns units (also see Section 3 Appendix 3 of the IPC manual) Hotel Services Enhanced cleaning with a hypochlorite solution should be undertaken by hotel service staff until instructed otherwise Following the removal of the patient, the room should have a terminal clean carried out prior to the next patient being admitted (also see Section 29 of the IPC manual) ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 6 of 7 Transferring Patients If possible, do not transfer patients until isolation is no longer required Prior to transfer, staff must inform any receiving ward/department that the patient has suspected/confirmed Group A Strep and if a specimen has been taken Prior to transfer, ensure the ward receiving the patient has suitable accommodation Inform and discuss with a member of the infection control team Specimens Send specimens as clinically indicated. If patient is not clinically improving after 48 hours of appropriate antibiotic therapy, take repeat specimens and contact a consultant microbiologist for advice. (also refer to the Laboratory Handbook via Athena) Care After Death Precautions for patient with iGas should be implemented if the patient dies prior to having appropriate antibiotic therapy - refer to Section 19 of the IPC Manual (also see Section 19 of the IPC manual) Patient Clothing If a relative or carer wishes to take personal clothing home, staff must place soiled clothing into a clear plastic bag then into a patients clothing bag. Staff must also ensure that a Home Laundry Information Leaflet is issued. A copy of this leaflet can be obtained by clicking on the link below. (also see Washing Clothes at Home information leafleT) Visitors No restrictions For iGAS during the infectious phase, visitors should be offered suitable information and relevant PPE following a risk assessment of their level of direct contact/involvement in the affected person’s care. This includes advice on hand hygiene. For further information please contact the IPCT or the on-call consultant Microbiologist. Outbreak situations Outbreaks can sometimes occur in healthcare and non-healthcare settings. The IPCT will advise staff in these situations. Staff screening may also have to be undertaken by Occupational Health and the IPCT will advise. An outbreak should be considered if there are 2 or more cases of suspected GAS infection related by person or place. 6.0 REFERENCES 1. Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK, Steer et al, Journal of Infection (2012) 64, 1e18. http://www.ips.uk.net/uploads/guidelines/NewStepAGuidelines.pdf last accessed 7th May 2012 2. Heymann, D L (2008), Control of Communicable Diseases Manual 19th Edition, American Public Health Association 3. CDC Group A strep (GAS) Disease available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.ht m last accessed 7th May 2012 ______________________________________________________________ Section 30, Group A Streptococcus (GAS) in a healthcare setting Issue No 1, October 2012 Page 7 of 7